Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Based on the search results, a specific product or standard combination named "Duracain + fentanyl + ropivacaine" was not found. The search results primarily discuss combinations of ropivacaine with fentanyl, and bupivacaine with fentanyl, particularly for epidural analgesia in labor and post-operative pain. Information regarding the queried combination is therefore limited, and it is treated as likely an incorrect or non-standard term for a clinical mix. Information below pertains largely to the Ropivacaine + Fentanyl combination as discussed in the search results: Ropivacaine + fentanyl is a combination used for epidural analgesia, especially in labor pain management and post-operative pain control. This combination is noted for providing effective pain relief with a lower incidence of motor blockade compared to bupivacaine-fentanyl combinations. Ropivacaine is an amide local anesthetic with lower lipophilic characteristics, associated with reduced potential for motor blockade and neurotoxicity. Fentanyl is an opioid analgesic that enhances the analgesic effect of ropivacaine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Duracain + fentanyl + ropivacaine.